"Drug Xeloda Prolongs Survival For Some Breast Cancer Patients" - Amy Norton
A drug called Xeloda can extend the lives of women whose breast cancer is not wiped out by standard treatment, a new clinical trial finds. Stephen Malamud, MD, associate professor of medical oncology at the Icahn School of Medicine at Mount Sinai said "Xeloda is a pill, so it's easy to take and is much less toxic than standard chemotherapy, most importantly, it extended overall survival in this study."
- Stephen Malamud, MD, Associate Professor, Medicine, Hematology, Medical Oncology, Icahn School of Medicine at Mount Sinai
Learn more
Additional Coverage:
HealthDay
WREX

Mount Sinai Researchers Discover How Melanoma May Spread to the Brain
Apr 30, 2025 View All Press Releases
Mount Sinai Showcases Innovative Cancer Research at 2025 AACR Annual Meeting in Chicago
Apr 24, 2025 View All Press Releases
Mount Sinai Leads Phase 3 Trial in Myelofibrosis Treatment
Mar 19, 2025 View All Press Releases
Mount Sinai Highlights Key Updates and Trends for Multiple Myeloma Awareness Month 2025
Mar 03, 2025 View All Press Releases
Mount Sinai Researchers Discover Why Some Colon Cancers Resist Treatment
Feb 12, 2025 View All Press Releases
Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study
Jan 09, 2025 View All Press Releases